Imaging Approaches in Prostate Cancer

March 19, 2014
Daniel P. Petrylak, MD

Daniel P. Petrylak, MD, director, Prostate and GU Medical Oncology, Yale Cancer Center, describes imaging approaches in prostate cancer.

Clinical Pearls I

Daniel P. Petrylak, MD, director, Prostate and GU Medical Oncology, Yale Cancer Center, describes imaging approaches in prostate cancer.

  • Sodium fluoride PET represents a sensitive way of detecting bone metastases
  • Sodium fluoride PET is reasonable to use before treatment with enzalutamide, sipuleucel-T, or abiraterone, in patients with rising PSA and negative conventional imaging

Clinical Pearls II

  • The Artemis device is being looked at in clinical studies to help detect prostate cancer in localized biopsies
  • Sodium acetate PET and amino acid imaging are still under investigation
  • Petrylak is interested in research into imaging for targeted therapies to check for activity and eligibility